Marko Trampuž

Dr. Marko Trampuž

Lek Pharmaceuticals d.d., Ljubljana, Slovenia
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Powder Technology
Verified
Journal Article
Closed access
Marko TrampužMarko Trampuž
Marko Trampuž
DTDušan Teslić
Dušan Teslić
BLBlaž Likozar
Blaž Likozar


1 January 2021 in Chemical Engineering Research and Design
Verified
Journal Article
Closed access
Marko TrampužMarko Trampuž
Marko Trampuž
DTDušan Teslić
Dušan Teslić
BLBlaž Likozar
Blaž Likozar

17 November 2022 in Processes
Verified
Journal Article
Open access
PDF file
MHMiha Homšak
Miha Homšak
Marko TrampužMarko Trampuž
Marko Trampuž
KNKlemen Naveršnik
Klemen Naveršnik
ZKZoran Kitanovski
Zoran Kitanovski
MŽMateja Žnidarič
Mateja Žnidarič
ZCZdenko Casar
Zdenko Casar
The ubiquitous presence of mutagenic and potentially carcinogenic N-nitrosamine impurities in medicines has become a major issue in the pharmaceutical industry in recent years. Rigorous mitigation strategies to limit their amount in drug products are, therefore, needed. The removal of nitrite, which is a prerequisite reagent for the N-nitrosation of amines, has been acknowledged as one of the most promising strategies. We have conducted an extensive literature search to identify nineteen structurally diverse nitrite scavengers and screened their activity experimentally under pharmaceutically relevant conditions. In the screening phase, we have identified six compounds that proved to have the best nitrite scavenging properties: ascorbic acid (vitamin C), sodium ascorbate, maltol, propyl gallate, para-aminobenzoic acid (PABA), and l-cysteine. These were selected for investigation as inhibitors of the formation of N-methyl-N-nitrosoaniline (NMA) from N-methylaniline and N-nitroso-N’-phenylpiperazine (NPP) from N-phenylpiperazine in both solution and model tablets. Much faster kinetics of NMA formation compared to NPP was observed, but the former was less stable at high temperatures. Vitamin C, PABA, and l-cysteine were recognized as the most effective inhibitors under most studied conditions. The nitrite scavenging activity does not directly translate into N-nitrosation inhibitory effectiveness, indicating other reaction pathways may take place. The study presents an important contribution to identifying physiologically acceptable chemicals that could be added to drugs to prevent N-nitrosation during manufacture and storage.

6 December 2024 in Organic Process Research & Development
Verified
Journal Article
Open access
TPTanja Poredoš
Tanja Poredoš
Marko TrampužMarko Trampuž
Marko Trampuž
TGTjaša Gornik
Tjaša Gornik
KNKlemen Naveršnik
Klemen Naveršnik
MTMaša Sinreih Tisnikar
Maša Sinreih Tisnikar
ZCZdenko Casar
Zdenko Casar
A surge in the approval of therapeutic oligonucleotides since 2016 has made this class of chemical modalities anessential toolbox for addressing unmet medical needs in the realm of rare or difficult-to-treat diseases. Therapeutic oligonucleotidesare complex drugs, primarily due to the active pharmaceutical ingredient, which presents numerous oligonucleotide-specificimpurities that are challenging to address during the manufacturing process. A less common challenge is the control of thestereochemical composition of P-chiral morpholino and phosphorothioate therapeutic oligonucleotides. These are produced in anon-stereoselective manner, resulting in a mixture of different stereoisomers that collectively form the final drug substance. Thus, thecontrol of stereochemical composition has an important role in the manufacturing process of therapeutic oligonucleotides, either asan in-process control or a final characterization test. In this Perspective, we first present the current status of oligonucleotidetherapeutics, with a focus on phosphorothioate derivatives. We then highlight the regulatory framework for controlling thestereochemical composition of these drugs, provide brief insights into the biological significance of stereochemical composition forphosphorothioates, and discuss the origin of stereochemical composition in the synthetic and downstream processes. Subsequently,we provide an in-depth analysis of analytical methods used to determine the stereochemical composition of therapeuticoligonucleotides, including liquid chromatography approaches in various separation modes and emerging modern techniques like ionmobility spectrometry. Furthermore, capillary electrophoresis, duplex melting temperature, and NMR spectroscopy are alsodiscussed in the context of stereochemical composition analysis of therapeutic oligonucleotides. Finally, we highlight novelenzymatic methods for cleaving therapeutic oligonucleotides into smaller fragments that can be analyzed for stereochemicalcomposition using standard techniques.

20 December 2022 in ACS Omega
Verified
Journal Article
Open access
Marko TrampužMarko Trampuž
Marko Trampuž
MŽMateja Žnidarič
Mateja Žnidarič
FGFabrice Gallou
Fabrice Gallou
ZCZdenko Casar
Zdenko Casar
N-nitrosamines are widespread cancerogenic compounds in human environment, including water, tobacco products, food, and medicinal products. Their presence in pharmaceuticals has recently led to several recalls of important medicines from the market, and strict controls and tight limits of N-nitrosamines are now required. Analytical determination of N-nitrosamines is expensive, laborious, and time-inefficient making development of simpler and faster techniques for their detection crucial. Several reports published in the previous decade have demonstrated that cobalt porphyrin-based chemosensors selectively bind N-nitrosamines, which produces a red shift of characteristic Soret band in UV–Vis spectra. In this study, a thorough re-evaluation of metalloporphyrin/N-nitrosamine adducts was performed using various characterization methods. Herein, we demonstrate that while N-nitrosamines can interact directly with cobalt-based porphyrin complexes, the red shift in UV–Vis spectra is not selectively assured and might also result from the interaction between impurities in N-nitrosamines and porphyrin skeleton or interaction of other functional groups within the N-nitrosamine structure and the metal ion within the porphyrin. We show that pyridine nitrogen is the interacting atom in tobacco-specific N-nitrosamines (TSNAs), as pyridine itself is an active ligand and not the N-nitrosamine moiety. When using Co(II) porphyrins as chemosensors, acidic and basic impurities in dialkyl N-nitrosamines (e.g., formic acid, dimethylamine) are also UV–Vis spectra red shift-producing species. Treatment of these N-nitrosamines with K 2 CO 3 prevents the observed UV–Vis phenomena. These results imply that cobalt-based metalloporphyrins cannot be considered as selective chemosensors for UV–Vis detection of N-nitrosamine moiety-containing species. Therefore, special caution in interpretation of UV–Vis red shift for chemical sensors is suggested.